Literature DB >> 6870212

Scopolamine psychosis revisited.

J G Cairncross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6870212     DOI： 10.1002/ana.410130524

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

Review 1.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Transdermal scopolamine cycloplegia in juvenile diabetes.

Authors:  A Lugaresi; A Uncini; F Chiarelli; P Cortelli
Journal:  Ital J Neurol Sci       Date:  1989-04

Review 3.  Pharmacokinetic considerations in the use of newer transdermal formulations.

Authors:  G Ridout; G C Santus; R H Guy
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

Review 4.  Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.